GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease
Dokumenttyp:
Zeitschriftenaufsatz
Autor(en):
Sachs, Stephan ; Götz, Anna ; Finan, Brian ; Feuchtinger, Annette ; DiMarchi, Richard D. ; Döring, Yvonne ; Weber, Christian ; Tschöp, Matthias H. ; Müller, Timo D. ; Hofmann, Susanna M.
Stichworte:
Research ; Novel Cardioprotective Antidiabetic Medications ; GIP agonist ; acyl-GIP ; Obesity ; Dyslipidemia ; Atherosclerosis ; Cardiometabolic disease ; Mice ; Medical and Health Sciences
Login
BibTeX